# BradyXplore Phase II: Bradykinesia Feature Extraction System

> **NCT02358876** · — · COMPLETED · sponsor: **Great Lakes NeuroTechnologies Inc.** · enrollment: 32 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02358876
- **Lead sponsor:** Great Lakes NeuroTechnologies Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2016-10-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02358876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02358876, "BradyXplore Phase II: Bradykinesia Feature Extraction System". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02358876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*